RS Group plc (FRA:ECN)

Intra-Cellular Therapies Revenue

In the fiscal year ending March 31, 2025, RS Group had annual revenue of 2.90B GBP, down -1.32%. RS Group had revenue of 1.46B in the half year ending March 31, 2025, a decrease of -4.07%.

• Revenue: 2.90B GBP
• Revenue Growth: -1.32%
• P/S Ratio: 0.85
• Revenue / Employee: 341.59K GBP
• Employees: 8,500
• Market Cap: 2.95B USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.90B	-38.90M	-1.32%
Mar 31, 2024	2.94B	-39.90M	-1.34%
Mar 31, 2023	2.98B	428.60M	16.78%
Mar 31, 2022	2.55B	551.00M	27.51%
Mar 31, 2021	2.00B	48.90M	2.50%